CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
CG Oncology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$59.96+0.11 (+0.18%)
Close on Oct 19, 2026
- Market cap
- $5.29B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of CG Oncology's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2026 | Jun 8, 2026 | SEC EDGAR |
| Current report | 8-K | May 20, 2026 | May 26, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 8, 2026 | SEC EDGAR |
| Current report | 8-K | May 8, 2026 | May 8, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 23, 2026 | Apr 24, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 13, 2026 | Apr 13, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 27, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2026 | Feb 27, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2026 | Jan 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 9, 2026 | Jan 9, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 22, 2025 | Nov 26, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2025 | Sep 9, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 5, 2025 | Sep 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 8, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2025 | Aug 8, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 7, 2025 | Jul 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2025 | Jun 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 26, 2025 | Apr 28, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 5, 2025 | Apr 25, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 28, 2025 | Mar 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2025 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 9, 2025 | Jan 10, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 5, 2024 | Dec 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 24, 2024 | May 24, 2024 | SEC EDGAR |
| Current report | 8-K | May 9, 2024 | May 9, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 9, 2024 | SEC EDGAR |
| Current report | 8-K | May 3, 2024 | May 3, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 26, 2024 | SEC EDGAR |